Home »
Academic Articles & Research Papers
Showing 20 of 266 academic articles
John M. Maris, Katherine K. Matthay • Journal of Clinical Oncology
(1999)
UNLABELLED: PURPOSE AND RESULTS: Neuroblastoma, the most common solid extracranial neoplasm in children, is remarkable for its clinical heterogeneity. Complex patterns of genetic abnormalities interact to determine the clinical phenotype. T...
OPENALEX
DOI: https://doi.org/10.1200/jco.1999.17.7.2264
Chun-Hua Wang, Lu-Kai Wang, Fu-Ming Tsai • Current Issues in Molecular Biology
(2025)
Tazarotene, a retinoid derivative, is widely used in treating skin conditions such as psoriasis and acne. Recent studies have demonstrated its potential as a promising therapeutic agent for treating melanoma in situ. Its primary mechanism o...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/cimb47040237
Akhilesh M Wodeyar, Sherin James, Benjamin B. Kasten, Nicolaus D. Knight et al. • Scientific Reports
(2026)
Abstract Achieving negative surgical margins remains a critical determinant of local recurrence and survival in head and neck cancer (HNC) surgery. Current intraoperative margin assessment techniques, including frozen section analysis, suff...
DOAJ
Open Access (DOAJ)
DOI: 10.1038/s41598-026-56078-4
Liu S, Lan J, Li J, Zhang Y et al. • Cancer Imaging
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1186/s40644-026-01099-5
PMC: PMC13737663
Li R, Cui S, Xu Y, Xing J et al. • Journal of Inflammation Research
(2018)
Ruijian Li,1–3,* Sumei Cui,1–3,* Youshun Xu,4 Junhui Xing,5 Li Xue,1–3 Yuguo Chen1–3 1Department of Emergency, Qilu Hospital, Shandong University, Jinan, China; 2Key Laboratory of Emergency and Critical Care Medicine...
DOAJ
Open Access (DOAJ)
Ugel S, De Sanctis F • Signal transduction and targeted therapy
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1038/s41392-026-03019-2
PMC: PMC13737155
Ansa-Addo EA, Azimnasab-Sorkhabi P, Huang HC, Riesenberg BP et al. • Nature communications
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1038/s41467-026-78360-9
PMC: PMC13736895
Tessa Suzanne van Schooten, Sarah Derks, Elena Jiménez-Martí, Fatima Carneiro et al. • BMC Cancer
(2022)
Abstract Background Gastric Cancer (GC) is the fourth most deadly cancer worldwide. Enhanced understanding of its key epidemiological and molecular drivers is urgently needed to lower the incidence and improve outcomes. Furthermore, tumor b...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s12885-022-09689-9
Safwaan H. Khan, Safwaan H. Khan, Yeonjoo Choi, Mysore Veena et al. • Frontiers in Immunology
(2025)
Chimeric antigen receptor (CAR) T cell therapy has revolutionized the treatment of hematologic malignancies, achieving remarkable clinical success with FDA-approved therapies targeting CD19 and BCMA. However, the extension of these successe...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2024.1489827
Zhou Z, Hong Y, You J, Que K et al. • Cell biology and toxicology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1007/s10565-026-10324-7
PMC: PMC13736382
Chen X, Cai Z, Zheng R, Zhang B et al. • Journal of clinical immunology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1007/s10875-026-02059-1
PMC: PMC13736372
Zhou M, Zhao L, Chen Z, Chen W et al. • Journal of translational medicine
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1186/s12967-026-08749-z
PMC: PMC13737794
Zhen Wang, Honglei Guo, Yanqi Song, Aidi Wang et al. • Frontiers in Immunology
(2025)
Lung cancer is the most common malignant tumor in the world. Presently, there are still problems, including a high recurrence rate, resistance, and serious toxic side effects, even if conventional treatments like chemotherapy, radiotherapy,...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2025.1597686
Katharina Schindler, Katharina Eva Ruppel, Claudia Müller, Ulrike Koehl et al. • Molecular Therapy: Methods & Clinical Development
(2024)
Chimeric antigen receptor (CAR) T cell therapies have demonstrated significant successes in treating cancer. Currently, there are six approved CAR T cell products available on the market that target different malignancies of the B cell line...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.omtm.2024.101328
Demi Brownlie, Andreas von Kries, Giampiero Valenzano, Nicole Wild et al. • OncoImmunology
(2023)
Lung cancer is a leading cause of cancer-related death worldwide. Despite recent advances in tissue immunology, little is known about the spatial distribution of tissue-resident lymphocyte subsets in lung tumors. Using high-parameter flow c...
DOAJ
Open Access (DOAJ)
DOI: 10.1080/2162402X.2023.2233402
• International Archives of Allergy and Immunology
(2015)
International Archives of Allergy and Immunology provides a forum for experimental and clinical research in modern molecular and cellular allergology and immunology. Appearing monthly, the journal publishes original work in the fields of al...
OPENALEX
DOI: https://doi.org/10.1159/issn.1018-2438
D.E. Milenic, B. Detrick, J.C. Reynolds, D. Colcher • The International Journal of Biological Markers
(1990)
Murine monoclonal antibodies (MAb) are currently being assessed for their utility as tools in cancer management. Anti-murine immunoglobulin responses have been observed in many patients receiving monoclonal antibody treatment. In this study...
DOAJ
Open Access (DOAJ)
DOI: 10.1177/172460089000500403
Yanpeng Feng, Zhiyuan Chen, Yi Xu, Yuxuan Han et al. • Frontiers in Immunology
(2023)
IκBζ (encoded by NFKBIZ) is the most recently identified IkappaB family protein. As an atypical member of the IkappaB protein family, NFKBIZ has been the focus of recent studies because of its role in inflammation. Specifically, it is a key...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2023.1188253
Angel Porgador • The Scientific World Journal
(2005)
Natural cytotoxicity receptors (NCRs), expressed by natural killer (NK) cells, trigger NK lysis of tumor and virus-infected cells on interaction with cell-surface ligands of these target cells. We have determined that viral hemagglutinins e...
DOAJ
Open Access (DOAJ)
DOI: 10.1100/tsw.2005.22
Honghui Zeng, Honghui Zeng, Xiaoqiang Yang, Xiaoqiang Yang et al. • Frontiers in Physiology
(2021)
Kidney diseases are highly prevalent and treatment is costly. Immune cells play important roles in kidney diseases; however, it has been challenging to investigate the contribution of each cell type in kidney pathophysiology. Recently, the ...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fphys.2021.752679